Spatial and temporal variation of routine parameters: pitfalls in the cerebrospinal fluid analysis in central nervous system infections.

Blood–CSF barrier Blood–brain barrier CSF flow Cerebrospinal fluid Intrathecal immunoglobulin synthesis Lactate

Journal

Journal of neuroinflammation
ISSN: 1742-2094
Titre abrégé: J Neuroinflammation
Pays: England
ID NLM: 101222974

Informations de publication

Date de publication:
06 Jul 2022
Historique:
received: 31 12 2021
accepted: 27 05 2022
entrez: 6 7 2022
pubmed: 7 7 2022
medline: 9 7 2022
Statut: epublish

Résumé

The cerebrospinal fluid (CSF) space is convoluted. CSF flow oscillates with a net flow from the ventricles towards the cerebral and spinal subarachnoid space. This flow is influenced by heartbeats, breath, head or body movements as well as the activity of the ciliated epithelium of the plexus and ventricular ependyma. The shape of the CSF space and the CSF flow preclude rapid equilibration of cells, proteins and smaller compounds between the different parts of the compartment. In this review including reinterpretation of previously published data we illustrate, how anatomical and (patho)physiological conditions can influence routine CSF analysis. Equilibration of the components of the CSF depends on the size of the molecule or particle, e.g., lactate is distributed in the CSF more homogeneously than proteins or cells. The concentrations of blood-derived compounds usually increase from the ventricles to the lumbar CSF space, whereas the concentrations of brain-derived compounds usually decrease. Under special conditions, in particular when distribution is impaired, the rostro-caudal gradient of blood-derived compounds can be reversed. In the last century, several researchers attempted to define typical CSF findings for the diagnosis of several inflammatory diseases based on routine parameters. Because of the high spatial and temporal variations, findings considered typical of certain CNS diseases often are absent in parts of or even in the entire CSF compartment. In CNS infections, identification of the pathogen by culture, antigen detection or molecular methods is essential for diagnosis.

Identifiants

pubmed: 35794632
doi: 10.1186/s12974-022-02538-3
pii: 10.1186/s12974-022-02538-3
pmc: PMC9258096
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

174

Informations de copyright

© 2022. The Author(s).

Références

Open Forum Infect Dis. 2019 Jul 1;6(7):
pubmed: 31363769
Neurosurgery. 1995 Oct;37(4):668-71; discussion 671-2
pubmed: 8559294
Neurology. 1993 Jan;43(1):169-75
pubmed: 8423881
J Pediatr. 1978 Dec;93(6):927-30
pubmed: 102754
Clin Chim Acta. 2001 Aug 20;310(2):173-86
pubmed: 11498083
In Vivo. 2018 May-Jun;32(3):583-590
pubmed: 29695564
J Neurol. 1982;228(3):171-80
pubmed: 6186790
J Neurosci. 2017 Mar 1;37(9):2395-2402
pubmed: 28137972
Am J Physiol. 1992 Jan;262(1 Pt 2):R20-4
pubmed: 1733335
Radiology. 2000 Sep;216(3):672-82
pubmed: 10966694
Nat Rev Neurosci. 2021 Jun;22(6):326-344
pubmed: 33846637
Cancer Res. 1986 Dec;46(12 Pt 1):6101-4
pubmed: 3096555
Expert Opin Med Diagn. 2013 Jul;7(4):343-64
pubmed: 23721048
Clin Pharmacokinet. 1998 Sep;35(3):223-46
pubmed: 9784935
Science. 2016 Jul 8;353(6295):176-8
pubmed: 27387952
Infez Med. 2017 Dec 1;25(4):320-325
pubmed: 29286010
Lancet. 2006 Jan 14;367(9505):182
pubmed: 16413882
BMC Infect Dis. 2020 Jun 22;20(1):441
pubmed: 32571220
Infect Dis (Lond). 2018 Jul;50(7):514-521
pubmed: 29490540
Clin Chem. 1974 May;20(5):571-3
pubmed: 4207912
Fluids Barriers CNS. 2017 Sep 27;14(1):25
pubmed: 28950883
Ann Pharmacother. 2012 Dec;46(12):e35
pubmed: 23232018
Scand J Infect Dis. 2001;33(12):909-13
pubmed: 11868764
Clin Microbiol Rev. 2020 Apr 29;33(3):
pubmed: 32349999
J Cell Biol. 1969 Mar;40(3):648-77
pubmed: 5765759
Diagnostics (Basel). 2021 Mar 28;11(4):
pubmed: 33800653
Surg Forum. 1950;:376-81
pubmed: 14828524
N Engl J Med. 2019 Jun 13;380(24):2327-2340
pubmed: 31189036
Antimicrob Agents Chemother. 2012 Aug;56(8):4416-21
pubmed: 22687507
J Neurol. 2005 Sep;252(9):1067-73
pubmed: 15789126
Fluids Barriers CNS. 2020 Nov 11;17(1):67
pubmed: 33176794
J Clin Oncol. 1995 Jan;13(1):177-9
pubmed: 7799017
Acta Neurochir (Wien). 1989;99(3-4):127-34
pubmed: 2773682
Clin Biochem. 2015 Jan;48(1-2):50-4
pubmed: 25445228
J Neural Transm (Vienna). 2012 Jul;119(7):739-46
pubmed: 22426833
Pharm Res. 1996 Jul;13(7):1065-8
pubmed: 8842046
Fluids Barriers CNS. 2016 Aug 31;13(1):15
pubmed: 27581842
PLoS One. 2017 Jul 19;12(7):e0180520
pubmed: 28723908
Infect Immun. 1983 Jul;41(1):275-9
pubmed: 6862627
Eur J Neurol. 2018 Feb;25(2):373-379
pubmed: 29115000
J Infect. 2011 Apr;62(4):255-62
pubmed: 21382412
Exp Neurol. 2015 Nov;273:57-68
pubmed: 26247808
Curr Drug Targets. 2019;20(10):1041-1057
pubmed: 30767741
J Comp Neurol. 1975 Nov 15;164(2):127-69
pubmed: 810497
Cerebrospinal Fluid Res. 2010 Jun 21;7:9
pubmed: 20565964
Medicine (Baltimore). 2008 Jul;87(4):185-192
pubmed: 18626301
Crit Care. 2021 Aug 11;25(1):291
pubmed: 34380543
Klin Wochenschr. 1958 Jan 15;36(2):66-9
pubmed: 13540120
Infect Drug Resist. 2015 May 15;8:119-28
pubmed: 26028977
Cancer Res. 1989 Feb 1;49(3):736-41
pubmed: 2491958
Acta Neurochir (Wien). 1993;121(1-2):1-8
pubmed: 8475800
Neurology. 1998 Dec;51(6):1710-4
pubmed: 9855528
Acta Neurol Scand. 2010 Aug;122(2):140-7
pubmed: 19814755
J Infect Dis. 1992 Sep;166(3):546-50
pubmed: 1500738
Clin Infect Dis. 2013 Jul;57(2):247-53
pubmed: 23592828
J Alzheimers Dis. 2014;41(4):1057-62
pubmed: 24748118
Pediatr Res. 2006 Aug;60(2):210-5
pubmed: 16864706
Arch Dis Child. 2005 Nov;90(11):1188-9
pubmed: 16243873
Acta Neuropathol. 1998 Nov;96(5):472-80
pubmed: 9829810
Postgrad Med. 1980 Oct;68(4):181-6, 187
pubmed: 7422599
Comput Med Imaging Graph. 2013 Apr;37(3):224-33
pubmed: 23570816
Clin Chim Acta. 2021 Feb;513:64-67
pubmed: 33316216
J Cell Mol Med. 2018 Oct;22(10):5151-5154
pubmed: 30054982
J Clin Invest. 1958 Oct;37(10):1419-24
pubmed: 13575543
Anesthesiology. 1998 Jul;89(1):24-9
pubmed: 9667290
Neurology. 2001 Nov 27;57(10):1763-6
pubmed: 11723260
Nature. 2015 Jul 16;523(7560):337-41
pubmed: 26030524
Front Neurol. 2019 Mar 26;10:281
pubmed: 30972012
J Neurol. 2002 Aug;249(8):1021-6
pubmed: 12195448
Blood. 1967 Oct;30(4):485-94
pubmed: 6054664
Acta Neurochir (Wien). 2004 May;146(5):477-81
pubmed: 15118885
Fluids Barriers CNS. 2014 Feb 12;11(1):3
pubmed: 24517462
J Infect Dis. 1981 Feb;143(2):141-7
pubmed: 7012246
Philos Trans R Soc Lond B Biol Sci. 2020 Feb 17;375(1792):20190154
pubmed: 31884922
J Nucl Med. 1965 Sep;6(9):632-44
pubmed: 4158030
Clin Chim Acta. 1987 Mar 30;163(3):319-28
pubmed: 3581475
Surg Neurol. 1976 Mar;5(3):187-210
pubmed: 1257894
PLoS One. 2012;7(8):e42745
pubmed: 22880096
Trends Pharmacol Sci. 2020 Jan;41(1):42-54
pubmed: 31839374
Fortschr Neurol Psychiatr. 1990 Nov;58(11):408-22
pubmed: 2279727
Pediatr Infect Dis J. 2006 Jan;25(1):8-11
pubmed: 16395095
PLoS One. 2014 Mar 17;9(3):e91974
pubmed: 24638077
Cell Tissue Res. 1988 Mar;251(3):621-31
pubmed: 3130190
Cell Mol Life Sci. 2021 Mar;78(6):2429-2457
pubmed: 33427948
Clin Microbiol Rev. 2010 Oct;23(4):858-83
pubmed: 20930076
J Neurol Neurosurg Psychiatry. 1987 Nov;50(11):1419-23
pubmed: 3694201
J Infect Dis. 1991 Jan;163(1):197-200
pubmed: 1984469
Fluids Barriers CNS. 2014 May 01;11:10
pubmed: 24817998
Cureus. 2020 Jul 21;12(7):e9315
pubmed: 32850195
Curr Protoc Toxicol. 2019 Jun;80(1):e72
pubmed: 30939232
Surg Neurol Int. 2018 Aug 03;9:155
pubmed: 30159199
J Neuroimmunol. 2007 Jul;187(1-2):139-46
pubmed: 17512988
BMC Infect Dis. 2019 Aug 5;19(1):692
pubmed: 31382892
Klin Wochenschr. 1958 Sep 15;36(18):857-63
pubmed: 13588925
J Clin Lab Anal. 2020 Feb;34(2):e23069
pubmed: 31602678
BMC Infect Dis. 2005 Oct 27;5:93
pubmed: 16253143
N Engl J Med. 1975 Dec 11;293(24):1215-20
pubmed: 1102982
Eur J Clin Pharmacol. 2017 Dec;73(12):1599-1607
pubmed: 28849406
Rev Neurol. 1999 May 16-31;28(10):996-8
pubmed: 10416239
J Neurosurg. 2003 May;98(5):1040-4
pubmed: 12744364
Arch Pediatr. 2008 Dec;15 Suppl 3:S126-32
pubmed: 19268242
Eur Neurol. 2002;47(4):224-32
pubmed: 12037437
JAMA. 1982 Jul 2;248(1):75-8
pubmed: 7087096
J Infect Dis. 1988 Nov;158(5):1142-3
pubmed: 3183426
J Exp Med. 2015 Jun 29;212(7):991-9
pubmed: 26077718
Clin Pharmacokinet. 2005;44(1):1-31
pubmed: 15634030
Neurology. 2012 May 15;78(20):1568-75
pubmed: 22517093
Am J Psychiatry. 1992 Oct;149(10):1369-73
pubmed: 1530074

Auteurs

Marija Djukic (M)

Institute of Neuropathology, University Medical Center, Göttingen, Germany.
Department of Geriatrics, Protestant Hospital Göttingen-Weende, An der Lutter 24, 37075, Göttingen, Germany.

Peter Lange (P)

Department of Neurology, University Medical Center, Göttingen, Germany.

Frank Erbguth (F)

Paracelsus Medical Private University, Nuremberg, Germany.

Roland Nau (R)

Institute of Neuropathology, University Medical Center, Göttingen, Germany. rnau@gwdg.de.
Department of Geriatrics, Protestant Hospital Göttingen-Weende, An der Lutter 24, 37075, Göttingen, Germany. rnau@gwdg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH